CAN-2409 works well for localized pro... - Fight Prostate Ca...

Fight Prostate Cancer

3,034 members1,515 posts

CAN-2409 works well for localized prostate cance

Maxone73 profile image
4 Replies

OK, we are the NFL of prostate cancer, not like those amateurs with localized cancer...but this news is worth! First of all, if you have Candel shares, congrats! a +172% raise in stock value is not peanuts. But what made me smile, is that immune therapy (in this case using a viral vector) is starting to work in prostate cancer too...plus who knows? They may want to test it also for advanced prostate cancer?

CAN-2409, a new viral immunotherapy, has shown promising results in treating prostate cancer. In a recent phase 3 clinical trial, it significantly improved disease-free survival when used with standard radiation therapy. The therapy works by using a gene that, when combined with a prodrug, kills tumor cells and triggers an immune response against the cancer. The safety profile of CAN-2409 is favorable, with mostly mild side effects. Based on these positive results, the company developing CAN-2409 plans to seek FDA approval.

prostatewarriors.com/2024/1...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Adendino profile image
Adendino

I love reading ALL your posts Max. Thank for being the bearer of good news and keeping us informed about the latest/greatest efforts out there to solve the puzzle or PCa. Your hard work is worth it and I appreciate every single one of your messages. Thank you!

Maxone73 profile image
Maxone73 in reply toAdendino

Thank you!

Steel67 profile image
Steel67

Is this therapy systemic or focal, if systemic couldn’t it theoretically be used as an adjuvant for Stage 4?

Maxone73 profile image
Maxone73 in reply toSteel67

Systemic...and what you said is exactly what I am hoping for!

Not what you're looking for?

You may also like...

Phase 3 trial for localized prostate cancer should be completed in December 2024

CAN-2409 is an immunotherapy drug currently in a Phase 3 clinical trial (PrTK03, NCT01436968) for...
Maxone73 profile image

Phase 1 starting soon: IDOV-Immune oncolytic platform!

You know I love the oncolytic virus approach! IDOV-Immune is a promising experimental cancer...
Maxone73 profile image

Warming Up the Cold: A New Hope for Immunotherapy in Prostate Cancer

Ok, Phase 1 data were encouraging, but the sample was small, only 35 patients. But 21% had a PSA...
Maxone73 profile image

Phase 2 trial: adaptive ADT for metastatic castration sensitive prostate cancer

The H. Lee Moffitt Cancer Center is advancing prostate cancer treatment with a Phase 2 trial...
Maxone73 profile image

Skin Patches vs. Traditional Hormone Therapy: A New Option for Metastatic Prostate Cancer?

I feel like...we will soon be all moved to estradiol! A phase 2 study from the STAMPEDE trial...
Maxone73 profile image

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.